Ondansetron
- Product NDC
- 70518-3512
- 11-digit product format
- 705183512
- Labeler code
- 70518
- Product ID
- 70518-3512_518ead3d-3105-ffd2-e063-6394a90a8647
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA078152
- Marketing category
- ANDA
- Marketing start
- 2022-09-07
- Substance
- ONDANSETRON
- Active strength
- 4 mg/1
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ondansetron
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ONDANSETRON | 4 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 4AF302ESOS |
| Rxcui | 104894 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70518-3512-0 | Ondansetron | 30 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 30 | | 13 |
| 70518-3512-1 | Ondansetron | 6 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 6 | | 13 |
| 70518-3512-2 | Ondansetron | 10 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 10 | | 13 |
| 70518-3512-3 | Ondansetron | 20 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 20 | | 13 |
| 70518-3512-4 | Ondansetron | 12 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 12 | | 13 |
| 70518-3512-5 | Ondansetron | 9 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 9 | | 13 |
| 70518-3512-6 | Ondansetron | 21 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 21 | | 13 |
| 70518-3512-7 | Ondansetron | 15 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 15 | | 13 |
| 70518-3512-8 | Ondansetron | 3 in 1 BOX, UNIT-DOSE | TABLET, ORALLY DISINTEGRATING | 3 | | 13 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70518-3512 | ONDANSETRON TABLET, ORALLY DISINTEGRATING [REMEDYREPACK INC.] | 7 | Current NDC, Legacy NDC, 9 package rows | 20250313_c0d827d0-333f-4187-ac75-9dc7d34b6169.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3512-0 | 70518351200 | 30 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-0) | 2022-09-07 | 0000-00-00 | No | No | Current |
| 70518-3512-1 | 70518351201 | 6 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-1) | 2022-09-29 | 0000-00-00 | No | No | Current |
| 70518-3512-2 | 70518351202 | 10 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-2) | 2023-10-20 | | No | No | Current |
| 70518-3512-3 | 70518351203 | 20 in 1 BOX, UNIT-DOSE | | | | | Historical |
| 70518-3512-4 | 70518351204 | 12 in 1 BOX, UNIT-DOSE | | | | | Historical |
| 70518-3512-5 | 70518351205 | 9 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-5) | 2023-12-23 | | No | No | Current |
| 70518-3512-6 | 70518351206 | 21 in 1 BOX, UNIT-DOSE | | | | | Historical |
| 70518-3512-7 | 70518351207 | 15 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-7) | 2025-03-06 | | No | No | Current |
| 70518-3512-8 | 70518351208 | 3 TABLET, ORALLY DISINTEGRATING in 1 BOX, UNIT-DOSE (70518-3512-8) | 2025-07-24 | | No | No | Current |